62 results
8-K
EX-3.1
IMGN
Immunogen, Inc.
12 Feb 24
Termination of a Material Definitive Agreement
7:52am
a corporation may specify par value in Article III. See G.L. Chapter 156D, Section 6.21, and the comments relative thereto. Common 100 $0.01 (a) Voting Rights
DEFM14A
IMGN
Immunogen, Inc.
2 Jan 24
Proxy related to merger
4:26pm
of consideration to be received.
Voting Rights. The holders of shares of common stock shall be entitled to one vote for each share so held with respect … or limits the right of the holder of the shares to vote on any matter, or to cumulate votes, except as such right may be limited by voting rights given
PREM14A
IMGN
Immunogen, Inc.
21 Dec 23
Preliminary proxy related to merger
4:52pm
by voting rights given to new shares then being authorized of an existing or new class; or
(v) reduces the number of shares owned by the shareholder
424B5
ogae 3n75dnkt
5 May 23
Prospectus supplement for primary offering
4:49pm
424B5
r8q36sk
3 May 23
Prospectus supplement for primary offering
4:05pm
8-K
EX-10.1
j34vfkcad
2 May 23
Entry into a Material Definitive Agreement
5:01pm
8-K
3vaygz
2 May 23
Entry into a Material Definitive Agreement
5:01pm
8-K
EX-3.1
99cu90nr 06m50
2 May 23
Entry into a Material Definitive Agreement
5:01pm
424B5
0aamqkg303ii2cp
3 Dec 21
Prospectus supplement for primary offering
4:06pm
424B5
g6ryb 9wz
30 Nov 21
Prospectus supplement for primary offering
5:12pm
424B5
400bzjb1sy
12 Aug 21
Prospectus supplement for primary offering
10:11am
424B5
lt12nq2 6l0zc658ve35
18 Dec 20
Prospectus supplement for primary offering
5:16pm
S-3ASR
EX-4.8
231d2gdk
18 Dec 20
Automatic shelf registration
4:45pm
S-3ASR
em8rvmnecfi kevv
18 Dec 20
Automatic shelf registration
4:45pm
S-3ASR
EX-4.7
ukdpevghzo0z9ucva1x
18 Dec 20
Automatic shelf registration
4:45pm
424B5
g5p2b15af igzuh
25 Sep 20
Prospectus supplement for primary offering
4:23pm